Current Clinical Pharmacology


Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA


Become EABM
Become Reviewer

Editorial [Hot Topic: Kidney Cancer: State of the Art in 2011 (Guest Editor: Ulka Vaishampayan)] promotion: free to download

Volume:6   Issue:3
Pp: 143-143
Ulka Vaishampayan
DOI: 10.2174/157488411797189370

Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma

Volume:6   Issue:3
Pp: 144-150
Michel Choueiri, Nizar Tannir and Eric Jonasch
DOI: 10.2174/157488411797189415

Immunotherapy of Kidney Cancer

Volume:6   Issue:3
Pp: 151-163
Petros D. Grivas and Bruce G. Redman
DOI: 10.2174/157488411797189406

Therapy for Non-Clear Cell Histologies in Renal Cancer

Volume:6   Issue:3
Pp: 169-180
Rhonda L. Bitting, John Madden and Andrew J. Armstrong
DOI: 10.2174/157488411797189460

Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma

Volume:6   Issue:3
Pp: 181-188
Priti Patel and Sandy Srinivas
DOI: 10.2174/157488411797189442

Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma

Volume:6   Issue:3
Pp: 189-198
Marc R. Matrana, Bradley Atkinson, Eric Jonasch and Nizar M. Tannir
DOI: 10.2174/157488411797189398

Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma

Volume:6   Issue:3
Pp: 214-221
Holleh D. Husseinzadeh and Jorge A. Garcia
DOI: 10.2174/157488411797189433